News & AnalysisUcello Therapeutics rallies $25m Series AUcello Therapeutics, a developer of CAR-T therapies, has closed $25 million in Series A financing.ByIris Dorbian11 February 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs